Aceminid usage and dosage guide: How to take it scientifically to achieve the best effect?
Asciminib is an ABL1 kinase inhibitor specifically used to treat patients with Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in the chronic phase. It achieves therapeutic effects by targeting the specific BCR-ABL1 fusion gene and blocking the growth and proliferation of cancer cells. The administration and dosage of Aceminid are critical to efficacy, so using this drug correctly is key to ensuring successful treatment.
The recommended dose of aceminib is40 mg twice daily, preferably on an empty stomach. This is because the absorption efficiency of the drug is higher on an empty stomach, which can ensure that the drug reaches the optimal therapeutic concentration in the body. For those patients who cannot tolerate taking it on an empty stomach, it is usually recommended to take it after a meal, but you should try to avoid taking it at the same time with high-fat food, as this may affect the absorption of the drug. During the medication process, patients should strictly follow the dosage and schedule according to the doctor's recommendations and avoid adjusting the dosage or skipping the dosage on their own.

It is best to take Aceminid at a fixed time, taking it at the same time every day, which helps maintain a stable concentration of the drug in the blood. The efficacy of drugs is closely related to blood drug concentration, so it is very important to maintain regular medication. If a patient forgets to take a dose, it should be taken as soon as possible after discovery, but if it is close to the next dose, the forgotten dose should be skipped and the medication should be continued according to the normal schedule. Never take a double dose at one time to make up for a missed dose, as this may cause adverse drug reactions.
While taking Asiminib, patients may experience some adverse reactions, such as fatigue, nausea, headache, etc. These are usually mild and may alleviate as treatment progresses. Doctors may adjust drug dosages or take other measures to reduce side effects based on the patient's specific condition. If serious adverse reactions or allergic reactions occur, seek medical attention immediately.
Reference materials:https://www.novartis.com/our-products/pipeline/asciminib
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)